Reports
Reports
Sale
The global digital patient monitoring devices market was valued at USD 119.7 billion in 2023, driven by increasing adoption of digitalization across the globe. The market is expected to grow at a CAGR of 19.76% during the forecast period of 2024-2032, with the values likely to reach USD 606.4 billion by 2032.
Chronic Fatigue Syndrome Treatment Market Size
Chronic Fatigue Syndrome Treatment Market Growth
Chronic Fatigue Syndrome Treatment Market Trends
Chronic Fatigue Syndrome Treatment Market Share
Chronic Fatigue Syndrome Treatment Regional Analysis
Chronic Fatigue Syndrome Treatment Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Digital Patient Monitoring Devices Market Overview
3.1 Global Digital Patient Monitoring Devices Market Historical Value (2017-2023)
3.2 Global Digital Patient Monitoring Devices Market Forecast Value (2024-2032)
4 Global Digital Patient Monitoring Devices Market Landscape*
4.1 Global Digital Patient Monitoring Devices: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Digital Patient Monitoring Devices: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Monitoring Type
5 Global Digital Patient Monitoring Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Digital Patient Monitoring Devices Market Segmentation (2017-2032)
6.1 Global Digital Patient Monitoring Devices Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Diagnostic Monitoring Devices
6.1.3 Therapeutic Monitoring Devices
6.2 Global Digital Patient Monitoring Devices Market (2017-2032) by Monitoring Type
6.2.1 Market Overview
6.2.2 Wireless Sensor Technology
6.2.3 mHealth
6.2.4 Telehealth
6.2.5 Wearable Devices
6.2.6 Remote Patient Monitoring
6.3 Global Digital Patient Monitoring Devices Market (2017-2032) by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Digital Patient Monitoring Devices Market (2017-2032)
7.1 North America Digital Patient Monitoring Devices Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Diagnostic Monitoring Devices
7.1.3 Therapeutic Monitoring Devices
7.2 North America Digital Patient Monitoring Devices Market (2017-2032) by Monitoring Type
7.2.1 Market Overview
7.2.2 Wireless Sensor Technology
7.2.3 mHealth
7.2.4 Telehealth
7.2.5 Wearable Devices
7.2.6 Remote Patient Monitoring
7.3 North America Digital Patient Monitoring Devices Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Digital Patient Monitoring Devices Market (2017-2032)
8.1 Europe Digital Patient Monitoring Devices Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Diagnostic Monitoring Devices
8.1.3 Therapeutic Monitoring Devices
8.2 Europe Digital Patient Monitoring Devices Market (2017-2032) by Monitoring Type
8.2.1 Market Overview
8.2.2 Wireless Sensor Technology
8.2.3 mHealth
8.2.4 Telehealth
8.2.5 Wearable Devices
8.2.6 Remote Patient Monitoring
8.3 Europe Digital Patient Monitoring Devices Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Digital Patient Monitoring Devices Market (2017-2032)
9.1 Asia Pacific Digital Patient Monitoring Devices Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Diagnostic Monitoring Devices
9.1.3 Therapeutic Monitoring Devices
9.2 Asia Pacific Digital Patient Monitoring Devices Market (2017-2032) by Monitoring Type
9.2.1 Market Overview
9.2.2 Wireless Sensor Technology
9.2.3 mHealth
9.2.4 Telehealth
9.2.5 Wearable Devices
9.2.6 Remote Patient Monitoring
9.3 Asia Pacific Digital Patient Monitoring Devices Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Digital Patient Monitoring Devices Market (2017-2032)
10.1 Latin America Digital Patient Monitoring Devices Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Diagnostic Monitoring Devices
10.1.3 Therapeutic Monitoring Devices
10.2 Latin America Digital Patient Monitoring Devices Market (2017-2032) by Monitoring Type
10.2.1 Market Overview
10.2.2 Wireless Sensor Technology
10.2.3 mHealth
10.2.4 Telehealth
10.2.5 Wearable Devices
10.2.6 Remote Patient Monitoring
10.3 Latin America Digital Patient Monitoring Devices Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Digital Patient Monitoring Devices Market (2017-2032)
11.1 Middle East and Africa Digital Patient Monitoring Devices Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Diagnostic Monitoring Devices
11.1.3 Therapeutic Monitoring Devices
11.2 Middle East and Africa Digital Patient Monitoring Devices Market (2017-2032) by Monitoring Type
11.2.1 Market Overview
11.2.2 Wireless Sensor Technology
11.2.3 mHealth
11.2.4 Telehealth
11.2.5 Wearable Devices
11.2.6 Remote Patient Monitoring
11.3 Middle East and Africa Digital Patient Monitoring Devices Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share by Top 5 Companies
17.2 Abbott Laboratories
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 AT&T Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Athenahealth Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 F. Hoffmann-La Roche AG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 General Electric Company
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Hill-Rom Holdings Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Johnson & Johnson
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Koninklijke Philips N.V
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications Mergers and Acquisitions
17.9.6 Certifications
17.10 Medtronic plc
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Nihon Kohden Corporation
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 OMRON Corporation
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 ResMed
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Digital Patient Monitoring Devices Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.